Recent Company News

• 07:45 PM ET May 07, 2025
  

  Aspen Pharmacare Holdings downgraded to equal-weight from overweight at Morgan Stanley (ZAR 118.92, 0.00)

• 02:14 AM ET May 06, 2025
  

  Aspen Pharmacare Holdings downgraded to underweight from equal weight at Absa Bank (ZAR 119.26, 0.00)

• 03:55 AM ET Apr 23, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (69 total)

• 12:59 AM ET Apr 23, 2025
  

  Aspen Pharmacare Holdings downgraded to underweight from overweight at JPMorgan (ZAR 161.64, 0.00)

• 11:08 AM ET Apr 22, 2025
  

  Aspen cuts FY25 manufacturing business EBITDA guidance amidst material contractual dispute; webcast tomorrow morning (ZAR 162.76, 0.00)

• 01:57 AM ET Mar 24, 2025
  

  Aspen Pharmacare Holdings downgraded to hold from buy at HSBC (ZAR 174.72, 0.00)

• 10:33 AM ET Mar 18, 2025
  

  FDA publishes Warning Letter sent to Aspen Pharmacare; company has suspended production of all drugs for US market (ZAR 180.04, +0.48)

• 06:06 AM ET Mar 03, 2025
  

  Aspen Pharmacare Holdings reports H1 HEPS ZAR645.40, +4% vs year-ago ZAR620.70 (ZAR 165.55, +2.25)

• 03:52 AM ET Jan 15, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (78 total)

• 06:53 AM ET Dec 13, 2024
  

  EU's CHMP adopted a positive opinion, recommending a change to the terms of the marketing authorisation for Amgen's Blincyto ($274.06, 0.00)